Reactivation of γ-globin expression using a minicircle DNA system to treat β-thalassemia
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- CRISPR/Cas9 systems targeting β-globin and CCR5 genes have substantial off-target activityNucleic Acids Research, 2013
- DNA targeting specificity of RNA-guided Cas9 nucleasesNature Biotechnology, 2013
- Minicircle DNA-based Gene Therapy Coupled With Immune Modulation Permits Long-term Expression of α-L-Iduronidase in Mice With Mucopolysaccharidosis Type IMolecular Therapy, 2011
- A robust system for production of minicircle DNA vectorsNature Biotechnology, 2010
- Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemiaNature, 2010
- Novel Minicircle Vector for Gene Therapy in Murine Myocardial InfarctionCirculation, 2009
- Improved Production and Purification of Minicircle DNA Vector Free of Plasmid Bacterial Sequences and Capable of Persistent Transgene Expression In VivoHuman Gene Therapy, 2005
- High-level transgene expression in primary human T lymphocytes and adult bone marrow CD34+ cells via electroporation-mediated gene deliveryGene Therapy, 2000
- A new DNA vehicle for nonviral gene delivery: supercoiled minicircleGene Therapy, 1997
- Ciprofloxacin, imipenem and rifampicin: in-vitro synergy of two and three drug combinations against Pseudomonas cepaciaJournal of Antimicrobial Chemotherapy, 1989